Literature DB >> 17377205

Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats.

Katarzyna Cieślik1, Bozena Klenk-Majewska, Zofia Danilczuk, Andrzej Wróbel, Tomasz Łupina, Grazyna Ossowska.   

Abstract

Zinc is an endogenous modulator of neuronal activity and may play an important role in the pathogenesis of depression. Recent studies have shown that zinc exhibits antidepressant-like activity in some models of depression in rodents. Our previous studies have shown that the footshock-induced fighting behavior was reduced in the rats subjected to chronic unpredictable stress (CUS). This test is used as the new experimental model of depression. Various antidepressant drugs given repeatedly prevented this kind of behavioral depression. The aim of the present study was to evaluate the effect of prolonged treatment with zinc hydroaspartate and to examine if zinc supplementation could modulate the imipramine effect in CUS model of behavioral depression in rats. The experiments were carried out on male Wistar rats. Chronic stress (persisting for 16 days) was induced by the modified method described by Katz et al. Zinc hydroaspartate at the dose of 30 mg/kg/day or 15 mg/kg/day and imipramine at the dose of 5 mg/kg/day were administered once daily for 14 days. Imipramine was given (ip) 1 h before every stress session and zinc hydroaspartate (ip) l h before the antidepressant. The footshock-induced fighting behavior test was performed 48 h after the last session of the chronic stress. It was demonstrated that in chronically stressed rats the number of fighting attacks was significantly reduced (by about 75%). Zinc hydroaspartate at the dose of 30 mg/kg/day, given alone, prevented the deficit in fighting behavior in chronically stressed rats. Neither imipramine at the dose of 5 mg/kg/day nor zinc hydroaspartate (15 mg/kg/day) administered alone changed the intensity of fighting behavior in chronically stressed rats. However, when imipramine was given at the same dose in the rats pretreated with zinc hydroaspartate (15 mg/kg/day) the deficit of fighting behavior was not observed. The present results indicate that zinc similarly to antidepressants protects the rats against the CUS-induced behavioral depression. Moreover, our findings suggest that zinc supplementation could potentiate the antidepressant effect of imipramine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377205

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  22 in total

1.  Peripheral zinc and neopterin concentrations are associated with mood severity in bipolar disorder in a gender-specific manner.

Authors:  Caitlin E Millett; Dahlia Mukherjee; Aubrey Reider; Adem Can; Maureen Groer; Dietmar Fuchs; Teodor T Postolache; Shannon L Kelleher; Erika F H Saunders
Journal:  Psychiatry Res       Date:  2017-05-17       Impact factor: 3.222

2.  Multiple pharmacological actions of Yiqi Huatan Decoction in a model of depression in rats.

Authors:  Hai-Hong Zhou; Shao-Dong Chen; Yin Xu; Yong-Zhu Han; Ji-Yuan Hu
Journal:  Chin J Integr Med       Date:  2012-03-14       Impact factor: 1.978

3.  The impact of zinc supplementation on galectin-3 and metabolic markers in diabetic patients on hemodialysis: A randomized, double-blind, placebo-controlled trial.

Authors:  Razieh Hosseini; Mansour Karajibani; Farzaneh Montazerifar; Elham Shahraki; Khatereh Babakhani; Ali Mohammad Mokhtari; Amirhossein Sahebkar
Journal:  J Diabetes Metab Disord       Date:  2022-05-14

Review 4.  Role of zinc in maternal and child mental health.

Authors:  Ann M DiGirolamo; Manuel Ramirez-Zea
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

5.  Antidepressant-like activity of zinc: further behavioral and molecular evidence.

Authors:  Magdalena Sowa-Kućma; Beata Legutko; Bernadeta Szewczyk; Kinga Novak; Paweł Znojek; Ewa Poleszak; Mariusz Papp; Andrzej Pilc; Gabriel Nowak
Journal:  J Neural Transm (Vienna)       Date:  2008-09-03       Impact factor: 3.575

6.  Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression.

Authors:  Luana M Manosso; Morgana Moretti; André R Colla; Camille M Ribeiro; Tharine Dal-Cim; Carla I Tasca; Ana Lúcia S Rodrigues
Journal:  J Neural Transm (Vienna)       Date:  2016-01-08       Impact factor: 3.575

7.  Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex.

Authors:  Magdalena Sowa-Kućma; Magdalena Kowalska; Marek Szlósarczyk; Krystyna Gołembiowska; Włodzimierz Opoka; Bogusław Baś; Andrzej Pilc; Gabriel Nowak
Journal:  Amino Acids       Date:  2010-06-09       Impact factor: 3.520

8.  Zinc homeostasis and neurodegenerative disorders.

Authors:  Bernadeta Szewczyk
Journal:  Front Aging Neurosci       Date:  2013-07-19       Impact factor: 5.750

9.  The effect of imipramine, ketamine, and zinc in the mouse model of depression.

Authors:  Andrzej Wróbel; Anna Serefko; Piotr Wlaź; Ewa Poleszak
Journal:  Metab Brain Dis       Date:  2015-07-10       Impact factor: 3.584

10.  Zinc deficiency is common in several psychiatric disorders.

Authors:  Ole Grønli; Jan Magnus Kvamme; Oddgeir Friborg; Rolf Wynn
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.